The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2019Pathogenesis of the Virome in Parkinson’s Disease
Study Rationale:
Numerous studies have implicated viruses as causal factors or potential triggers for Parkinson’s disease (PD). Our study will provide a comprehensive understanding of all the viral... -
Astrocyte Biology in Parkinson's Disease, 2019Astrocyte Gene Expression in Parkinson’s Interrogated Using Single Cell Nuclear RNA Sequencing
Study Rationale:
Astrocytes are one of the major non-neuron cell types in the brain and control many neurological processes. They are likely to be changed in Parkinson’s disease (PD) and may... -
MJFF Research Grant, 2013Specific Modulation of Tau Oligomers by Passive Immunotherapy in a Parkinson's Disease Model
Objective/Rationale:
The accumulation of tau protein is an important pathogenic factor in Parkinson’s disease (PD) and other neurodegenerative disorders. Our recent findings from pre-clinical models... -
MJFF Research Grant, 2012Novel PD Tools: Generation of Posttranslationally Modified Alpha-synuclein
Objective/Rationale:
There is increasing evidence linking specific posttranslational modification (folding, cutting, etc. of proteins before maturation) and alpha-synuclein aggregation... -
LRRK2 Challenge, 2013In Vivo Rescue of Dopamine Release Deficits via Kinase Inhibition in LRRK2 Mutant Mice
Objective/Rationale:
Abnormal kinase activity is thought to be responsible for the pathogenic effects of LRRK2 in parkinsonian patients and many lines of evidence point towards a role of... -
Research Grant, 2013Validation of Blood-borne Autoantibody Biomarkers for Parkinson’s Disease Supplement
Promising Outcomes of Original Grant:
The purpose of the original study was to determine if a small group of selected blood-borne autoantibody biomarkers that were previously shown to be effective in...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.